Physician profile
Michael Cohen
NPI 1619984937
$276,872.60
in general payments reported to CMS, 2019-2025
8 companies · $38K in 2025
The $38K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55K · 2020: $12K · 2021: $34K · 2022: $39K · 2023: $33K · 2024: $67K · 2025: $38K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $73K · Consulting Fee: $47K · Travel and Lodging: $12K · Food and Beverage: $4,676 · Honoraria: $700 · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $73,205.72 |
| Consulting Fee | $46,950.33 |
| Travel and Lodging | $12,064.98 |
| Food and Beverage | $4,676.14 |
| Honoraria | $700.00 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $130,698.56 | 2019-2022 | |
| Abbvie INC. | $129,408.31 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Davol INC. | $11,186.04 | 2022-2025 | Arista Ah Flexitip |
| Motiva USA, LLC | $3,067.50 | 2024-2025 | |
| Tepha INC | $2,250.00 | 2020 | |
| Galderma Laboratories, L.P. | $160.27 | 2019-2025 | Dysport |
| Integra Lifesciences Corporation | $52.44 | 2022-2023 | Durasorb Monofilament Mesh |
| Mentor Worldwide LLC | $49.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.